TWO · —

InnoPharmax Inc. (4172.TWO) Stock

$9.92 -0.70% TWO: 4172.TWO —

—

Valuation

Metric	Value
Price	$9.92
Market Cap	$1.23B
P/E Ratio	—
P/B Ratio	2.31
P/S Ratio	18.17
EPS (TTM)	$-1.83
52-Week High	$23.25
52-Week Low	$9.47
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-37.62%
ROA	-20.48%
ROCE	—
Gross Margin	19.60%
Operating Margin	-143.67%
Net Margin	0.00%
Debt/Equity	0.02
Current Ratio	6.42

About InnoPharmax Inc.

—

InnoPharmax Inc. is led by CEO Weihua Hao, employs 33 people, headquartered in Taipei, TW, publicly traded since 2012.

InnoPharmax Inc. (4172.TWO) stock trades at $9.92 with a market capitalization of $1.23B. The stock is valued at price-to-book of 2.31, price-to-sales of 18.17. Over the past 52 weeks the stock has ranged between $9.47 and $23.25, and currently trades 57.3% below its 52-week high.

On profitability, InnoPharmax Inc. generates a return on equity (ROE) of -37.62% (negative, reflecting a net loss), an operating margin of -143.67%.

Official website: www.innopharmax.com

InnoPharmax Inc. (4172.TWO) — frequently asked questions

What is InnoPharmax Inc. (4172.TWO) stock price today?

InnoPharmax Inc. (4172.TWO) is currently trading at $9.92, down 0.7% today.

What is 4172.TWO return on equity (ROE)?

InnoPharmax Inc.'s return on equity (ROE) is -37.62%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is InnoPharmax Inc.'s market cap?

InnoPharmax Inc. has a market capitalization of $1.23B.

Does 4172.TWO pay a dividend?

InnoPharmax Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does 4172.TWO carry?

InnoPharmax Inc. has a debt-to-equity ratio of 0.02. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 4172.TWO's profit margin?

InnoPharmax Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.

What sector is 4172.TWO in?

InnoPharmax Inc. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 4172.TWO listed on?

InnoPharmax Inc. trades on TWO under the ticker 4172.TWO.

What is 4172.TWO's 52-week range?

Over the last year InnoPharmax Inc. has traded between $9.47 and $23.25.

Related — Stocks

HONA Honeywell Aerospace Inc. $167.90 -0.44% USDE StablecoinX Inc. $1.00 -0.01% SSMR Sunshine Silver Mining & Refining Company $14.18 +8.33% GENB Generate Biomedicines, Inc. $13.21 +6.96% PURR Hyperliquid Strategies Inc $9.85 +8.60% HAWK HawkEye 360, Inc. $13.52 +5.96% SPTX Seaport Therapeutics, Inc. $21.28 +2.16% HBNB Hotel101 Global Holdings Corp. $4.77 +7.98% WHK WhiteHawk Minerals Corp $26.81 +2.92% GMRS GMR Solutions Inc. $10.66 -1.39% AGMB AgomAb Therapeutics NV - ADRs representing one common share. $8.40 -1.98% DYNC Dynamix Corporation - Class A Ordinary Share $10.91 +0.32%

Screens 4172.TWO currently matches

On the figures above, InnoPharmax Inc. passes the filters for 9 of our ready-made screens, among them Low Debt Stocks, Small Cap Stocks, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low Debt Stocks Small Cap Stocks Stocks Under $10 Debt Free Stocks Under $100 Debt Free Stocks Stocks Under $100 Stocks Under $50 Debt to Equity Below 1 Stocks High Current Ratio Stocks

Related stock screens

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.